Petrie-Flom Center: Health Law, Biotech and Bioethics

Experts cite the complexity of the problem of homelessness, which is rooted in poverty and lack of affordable housing, but includes medical, psychiatric and substance-use issues.

Psychedelic drugs show promise as a new treatment option for some psychiatric maladies, but experts see a possible state and federal legal clash.

I. Glenn Cohen ’03 has always been fascinated with how things and people work, and with parsing thorny ethical dilemmas. He loves science and the law, and he’s been blending those passions for years as a legal scholar focused on bioethics.

Harvard Law School’s Carmel Shachar examines a lawsuit by pharmaceutical giant Merck contesting a provision of the Inflation Reduction Act.

Susannah Baruch has joined the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School as executive director.

Harvard Law School expands the ranks of its faculty with four appointments.

Carmel Shachar J.D./M.P.H. ’10 has been appointed assistant clinical professor and faculty director of the Health Law and Policy Clinic at Harvard Law School.

Speakers at a Radcliffe Institute conference look at the divisive, fraught history of Roe v. Wade and predict where legal battles will go next.

Harvard Law expert Carmel Shachar says if California wins its suit against drug manufacturers, it could make the lifesaving drug more affordable for everyone.

Harvard Law panelists say both exploit how brains process information.

Harvard Law Clinical Professor Robert Greenwald retires after a long career securing health care access for vulnerable populations.

This fall, Harvard Law School showcased the works of faculty, alums, and students at book events throughout the semester.

This article was originally published in the Harvard Gazette. Mexico and Colombia recently legalized abortion in landmark rulings that offer a stark contrast to…

The Petrie-Flom Center hosted ‘Roe in limbo: A town hall on the leaked Dobbs opinion.’

A new Harvard Law initiative examines the legal and ethical aspects of therapeutic psychedelics

Glenn Cohen and Carmel Shachar reflect on the administration’s successes, failures, and agenda for the future.

The new Project on Psychedelics Law and Regulation (POPLAR) at Harvard Law School recently convened a conference on the future of psychedelics law and regulation.

The Petrie-Flom Center at Harvard Law School has announced a new research initiative, the Project on Psychedelics Law and Regulation, to promote safety, innovation, and equity in psychedelics research, commerce, and therapeutics.